
ABOUT KAYENTIS
Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2003, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases II/III across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company has conducted digital data collection for over 280 clinical trials in 85 countries (18,000 sites and 98,000 patients), employing 120 languages. It has offices in the US (Boston), France (Grenoble) and Japan (Tokyo), and currently employs 185 staff.
Follow us on LinkedIn to discover new content every week!
NEWS
FEATURED ARTICLES
-
Set explicit expectations about what "bring your own device" strategies should be, the associated risks, and propose structured help to support successful decision-making processes and implementation.
-
Understanding the rare disease framework is key to being able to offer study participants adapted solutions and positively contribute to clinical research.
-
Discover how cancer patients can teach healthcare providers and industry stakeholders to resolve disparities related to cultural differences, individual preferences, and more, to add value to clinical research studies.
-
Curious about the risks linked to data collection from home? Learn how clinical teams are identifying and mitigating those risks and the strategies to support resilience, data credibility, and data privacy.
-
Despite the evolution in pediatric legislation and a renewed interest in developing therapeutics for pediatric and rare diseases, pediatric clinical research remains deeply challenging.
-
Explore how asking patients about the impact of the study procedures on their day-to-day life is key when it comes to reflecting on future protocols.
-
Basile Trimbur, Kayentis Medical Assistant, interviews Trishna Bharadia, Health Advocate & Patient Engagement Advisor, on decentralized clinical trials and their impact on health disparities.
-
Obtaining direct patient feedback on various aspects of the study provides valuable insights into how they perceive their own study experience. Discover three key reasons for implementing a Participant Feedback Questionnaire.
VIDEOS
CONTACT INFORMATION
Kayentis
186 South Street Suite 600
Boston, MA 02111
UNITED STATES
Contact: Guillaume Juge, CEO
BROCHURES
-
Results of a survey of investigator sites conducted in November 2022, and co-developed with a group of worldwide site experts: 239 site respondents across the world, in various roles, and carrying out research across multiple therapeutic areas.
-
Improve your eCOA data collection and clinical trial efficiency with Kayentis and ClinOne's combined solution, covering eCOA, virtual visits, consent management, patient engagement, and more.
-
Discover why 95.6% of Kayentis’ clients recommend Kayentis as eCOA and DCT provider in 2023.
-
Gain insight on how a single point of entry can improve patient and site experience by offering best-in-class eCOA, consent management, and patient engagement solutions.
-
Discover how Kayentis' governance structure is made to manage Big Pharma needs and builds long-term relationships.
-
Benefit from Kayentis’ data management culture for all your clinical studies and consider data management at each step of your study.
-
Learn how the Kayentis Media Player (KMP) allows relevant information to be provided regularly through very user-friendly technology.
-
Dedicated to improve patient experience in clinical trials, Kayentis’ Clin’form solution offers the flexibility to customize questionnaire design with illustrations to better fit population preferences, especially to adapt to young patient populations.
-
Learn about the Clin’form App, your BYOD solution for all your clinical studies.
-
Learn how Kayentis can reduce project CO2 emissions without impacting cost, quality or timelines.
-
As digitalization of clinical trials accelerates, explore how using the single platform and implementing robust technology integration from Kayentis will help to improve patients’ experience.
-
Kayentis offers extensive expertise in dermatology with a solid experience with several typical PROs and Patient Diaries.
-
Choose a strong partner to ensure the success of your decentralized clinical trials.
-
Being human means that the way data is completed can create inconsistencies, issues, and more questions than you had perhaps anticipated. That is why it is essential to consider data management from the very start of each study.
-
Read about how Kayentis developed innovative eCOA solutions for capturing the patient’s voice in clinical trials.
-
Kayentis is a Global Provider Of Electronic Clinical Outcome Assessments for capturing the patient’s voice in clinical trials.